Methylphenidate dose optimization for ADHD treatment: review of safety, efficacy, and clinical necessity
Michael Huss,1 Praveen Duhan,2 Preetam Gandhi,3 Chien-Wei Chen,4 Carsten Spannhuth,3 Vinod Kumar5 1Child and Adolescent Psychiatry, University Medicine, Mainz, Germany; 2Global Medical Affairs, Novartis Healthcare Pvt. Ltd., Hyderabad, India; 3Development Franchise, Established Medicine Neuroscienc...
Guardado en:
Autores principales: | Huss M, Duhan P, Gandhi P, Chen CW, Spannhuth CW, Kumar V |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c6b9b283f2d5497aa7c00386ee560f18 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Tratamiento del síndrome de déficit atencional (SDA) en niños: evaluación de la moclobemida, una alternativa no psicoestimulante
por: Valdivieso,Alicia, et al.
Publicado: (2000) -
Patterns of Response to Methylphenidate Administration in Children with ADHD: A Personalized Medicine Approach through Clustering Analysis
por: Silvia Grazioli, et al.
Publicado: (2021) - The ADHD report
-
Estimated prevalence and incidence of diagnosed ADHD and health care utilization in adults in Sweden – a longitudinal population-based register study
por: Polyzoi M, et al.
Publicado: (2018) -
Effects of melatonin in children with attention-deficit/hyperactivity disorder with sleep disorders after methylphenidate treatment
por: Masi G, et al.
Publicado: (2019)